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NLRX1: friend  
or foe?
Mitochondria are known to be semi-autonomous organelles that 
are responsible for energy production and cellular respiration. 
Mitochondria break down glucose to release energy in the form of 
atp through oxidative phosphorylation. However, as a by-product, 
a steady stream of reactive oxygen species (roS) is released from 
these cellular powerhouses. roS can potentially cause damage to 
cellular components, and are therefore closely linked to diseases 
such as alzheimer disease and cancer.
recently, mitochondria were also found to have a crucial role in 
innate immunity. innate immune responses against invading viruses 
rely on the detection of viral pathogen-associated molecular patterns 
(paMps) and the subsequent production of antiviral cytokines such 
as type i interferons (iFns). one prototypical viral paMp is double- 
stranded (ds)rna, which can be detected by toll-like receptor 3 
(tlr3) in endosomes (akira & takeda, 2004). tlr3 was the first 
reported dsrna receptor able to signal to interferon regulatory factor 
(irF) and nF-κB, which are essential transcription factors that regu-
late type i iFn production (Fig 1). Since then, two homologous rna 
helicases—retinoic-acid-inducible gene i (rig-i) and melanoma- 
differentiation-associated protein 5 (MDa5)—have been identified as 
cytoplasmic sensors of viral-derived rna (yoneyama et al, 2004).
the rig-like helicases (rlHs), rig-i and MDa5, both con-
tain two amino-terminal caspase recruitment domains (carDs) 
and an rna helicase domain (Fig 1; Meylan et al, 2005). During 
viral infection, rig-i and MDa5 trigger the activation of nF-κB, 
irF3 and irF7, which cooperate in the induction of antiviral 
type i iFn (Fig 1). rig-i—but not MDa5—mounts an antiviral 
response against 5'ppprna molecules present during the repli-
cation of certain single-stranded (ss)rna viruses, such as Sendai 
virus and influenza virus. By contrast, MDa5 detects the pres-
ence of synthetic poly i:c—a synthetic dsrna analogue—and the 
positive-strand ssrna picornavirus encephalomyocarditis virus 
(takeuchi & akira, 2007). Mechanistically, rig-i and MDa5 use 
their carDs to connect with cardif (also known as MaVS, ipS1 or 
ViSa) and initiate downstream events (Kawai et al, 2005; Meylan 
et al, 2005; Seth et al, 2005; Xu et al, 2005). cardif contains an 
n-terminal carD that interacts with both rig-i and MDa5, 
whereas its carboxyl terminus contains a membrane-anchor 
region—similar to the anti-apoptotic Bcl2—which targets cardif 
to the outer mitochondrial membrane (Fig 1). When cardif is 
released from the mitochondria into the cytoplasm, it no longer 
mediates downstream irF and nF-κB activation (Meylan & 
tschopp, 2006). once activated by viral rna, cardif recruits 
appropriate signalling intermediates, such as iκB kinases (iKKs, 
namely iKKα, β, ε and tanK-binding kinase 1 (tBK1)), to activate 
nF-κB and irF transcription factors (Fig 1).
the importance of antiviral systems are often highlighted by 
the number of viruses that target the signalling pathway; for exam-
ple, cardif is cleaved and inactivated by the hepatitis c virus (HcV; 
Meylan et al, 2005). owing to the importance of this antiviral mito-
chondrial pathway, it therefore seems reasonable that it could be 
tightly controlled by other cellular proteins. this would ensure the 
inhibition of unwarranted—and possibly deleterious—antiviral 
responses. recently, further insights have been gained into the mech-
anism by which cells control these potentially harmful signalling 
events (Fig 1). First, suppressor of iKKε (SiKE), which interacts with 
the kinases tBK1 and iKKε, inhibits both rlH and tlr-dependent 
irF activation by preventing interactions between various proteins 
and these two kinases (Huang et al, 2005). Second, pin1, a peptidyl- 
prolyl isomerase, interacts with phosphorylated irF3 and promotes 
its polyubiquitination and proteasome-dependent degradation 
(Saitoh et al, 2006). in two recent reports—one by Jenny ting’s group 
in Nature (Moore et al, 2008) and the other by Stephen girardin and 
colleagues in this issue of EMBO reports (tattoli et al, 2008)—an 
additional mitochondrial protein, nlrX1, was found to modulate 
innate immune responses.
nlrX1 is a member of the cytoplasmic noD-like receptors 
(nlrs; Fritz et al, 2006; Martinon et al, 2007). the most under-
stood nlr members are nalp3 (also known as cryopyrin) and 
noD2. nalp3 detects exogenous and host ligands, such as bacte-
rial peptidoglycan, atp or uric acid (petrilli et al, 2007), and recruits 
the inflammatory caspase 1 through the adaptor protein aSc. this 
forms an interleukin-1β-processing molecular complex termed the 
‘inflammasome’ (agostini et al, 2004; petrilli et al, 2007). noD2 
is a nF-κB-activating nlr, which detects the bacterial paMp 
muramyl-dipeptide (Franchi et al, 2008). noD2 has attracted much 
attention as mutations in NOD2 are associated with crohn disease 
(le Bourhis et al, 2007). By contrast, almost nothing is known about 
the biological function of nlrX1. this nlr protein is highly con-
served between species and is expressed ubiquitously. nlrX1 is a 
close sequence homologue of noD3—one of six members of the 
noD subfamily of nlrs—and is also called noD5 or noD9; 
unfortunately, the nomenclature of nlrs is confusing, particularly 
since the recent introduction of additional names by the Human 
genome organization. noD subfamily members commonly have 
a carD at their n-terminus, followed by a nacHt domain and 
several leucine-rich repeat domains (Martinon et al, 2007). nlrX1 
(noD5) is distinct as it lacks the n-terminal carD, which is instead 
replaced by a putative mitochondrial targeting sequence located 
within the first 20 amino acids. indeed, nlrX1 was found to local-
ize to mitochondria (tattoli et al, 2008)—more precisely to their 
outer membrane (Moore et al, 2008)—provided that this crucial 
n-terminal sequence is present. on the basis of this subcellular 
localization, the authors of both studies searched for a function of 
nlrX1 that is connected to the known roles of mitochondria.
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interestingly, although the two functions of nlrX1 identified by 
the different groups are indeed both related to mitochondria, they 
are not identical and, at first glance, seem to be mutually exclu-
sive. ting’s group proposes that the nacHt domain of nlrX1 
interacts physically with the carD of cardif (Moore et al, 2008). 
as this domain is required for the interaction of cardif with rlHs, 
competition between nlrX1 and rlH is predicted. indeed, over-
expression of nlrX1 disrupts the rlH–cardif interaction induced 
by Sendai virus and consequently interferes with iFn-β production. 
Similarly, rlH-induced irF3 and nF-κB activation (triggered by 
transfection of poly i:c) is inhibited, resulting in impaired iFn-β pro-
duction (Fig 1). importantly, replication of Sindbis virus is highly 
attenuated in the presence of nlrX1 small interfering rna. By 
contrast, the tlr3 signalling pathway is not affected as both iFn-β 
and nF-κB reporter assays remain normal when poly i:c is added 
to the cellular exterior, showing the specificity of nlrX1 for the 
cytoplasmic antiviral effector system.
in contrast to ting’s results, no inhibitory function of nlrX1 on 
the iFn-β and nF-κB signalling pathways is reported by girardin’s 
group (tattoli et al, 2008). instead, amplified activity of nF-κB, and 
c-Jun n-terminal kinase ( JnK), is observed on overexpression of 
nlrX1 following activation of these pathways by tumour necrosis 
factor (tnF) or Shigella. Mechanistically, this is explained by the 
observation that overexpression of nlrX1 leads to the generation 
of roS. Furthermore, nlrX1 further increases roS production 
induced by poly i:c, tnF and Shigella. it is well documented that 
roS potentiates pro-inflammatory signalling pathways (gloire 
et al, 2006) and as several pro-inflammatory stimuli, such as bac-
terial and viral infections, are also known to trigger roS (gloire 
et al, 2006), the observed synergism of nlrX1 and poly i:c, tnF or 
Shigella seems possible. nlrX1 lacking the mitochondrial anchor 
sequence is inactive, which suggests that the increased roS pro-
duction is of mitochondrial origin and not attributable to, for exam-
ple, increased activity of one of the naDpH oxidases. However, the 
precise amplification mechanism remains elusive.
the data published by the two groups have important biological 
consequences. nlrX1 is the first nlr member that is constitutively 
localized to the mitochondria—nalp1 binds only transiently to 
Bcl2 and Bcl-Xl. in addition to the mitochondrial targeting signal, 
nlrX1 uses its nacHt domain to interact with cardif and there-
fore mitochondrial association seems to be enforced. nevertheless, 
this direct nlrX1–cardif interaction must be weak as deletion of 
the mitochondrial targeting sequence abolishes the mitochondrial 
localization of nlrX1 and also its function. Furthermore, proteins 
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Fig 1 | Mitochondria as anti-pathogen platforms. Through its mitochondrial anchor (MA) sequence, Cardif is targeted to the outer membrane of mitochondria, 
where it orchestrates RLH-dependent antiviral responses through the recruitment of both viral RNA sensors (RIG-I or MDA5) and effector proteins (IKK). Several 
cellular (SIKE, PIN1) but also viral (for example, the protease of HCV) proteins tightly regulate the antiviral response. NLRX1, another mitochondria-targeted 
protein (MT), might act as a negative regulator of Cardif signalling, diminishing virally induced Cardif–RLH interactions. However, NLRX1 also promotes ROS 
production at the mitochondria, which consequently helps to fight bacteria and viruses. How NLRX1 performs these functions, and how it becomes activated, 
remain unanswered questions. CARD, caspase recruitment domain; HCV, hepatitis C virus; IFN, interferon; IKK, IκB kinase; IRF, interferon regulatory factor; 
MDA5, melanoma-differentiation-associated protein 5; NLRX1, NOD-like receptor X1; PIN1, peptidylpropyl isomerase 1; RIG-I, retinoic-acid-inducible gene I; 
ROS, reactive oxygen species; RLH, RIG-like helicase; SIKE, supressor of IKKε; TBK, TANK-binding kinase.
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with mitochondrial targeting sequences are usually imported into 
the mitochondria by crossing at least the outer membrane, making 
an interaction with cardif difficult to explain.
Both reports agree on the mitochondrial localization of nlrX1, but 
the proposed functions of nlrX1 are different. ting’s group identifies 
nlrX1 as an inhibitor of antiviral mitochondrial signalling. the evi-
dence for such a role seems convincing as markedly increased iFn-β 
responses are clearly observed in cells with downregulated nlrX1 
expression. However, a pronounced effect on the replication activity of 
a non-modified virus such as vesicular stomatitis virus or Sendai virus 
has not been shown. How can we reconcile ting’s data with the idea of 
girardin’s, which identifies nlrX1 as an amplifier of roS generation? 
roS are required for irF3 (chiang et al, 2006) and Stat activation 
(liu et al, 2004), and are therefore clearly implicated in the antiviral 
innate immune response. it is counterintuitive that nlrX1 activates an 
antiviral response while at the same time inhibits this response. one 
explanation for this dilemma is to postulate that nlrX1 first suppresses 
spontaneous activation of the rlH–cardif pathway but, on activation 
of the rlH by viruses, nlrX1 dissociates from cardif, converting it into 
an antiviral molecule by increasing roS production at the mitochon-
dria. this latter function might be more in line with the general function 
of nlrs—that is, the detection and elimination of danger. alternatively, 
putative antiviral functions of nlrX1 might dominate over its proviral 
role in certain cell types, or in the context of infections with particular 
viruses, and vice versa. We will have to wait for the generation of mice 
that are deficient in nlrX1 to determine fully the role of this new mito-
chondrial protein. nevertheless, the two studies do confirm the emer-
ging role of mitochondria not only as powerhouses of the cell but also 
as crucial regulators of immunity.
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